Partner Developed Content & Underwritten Introduction

patientjourneyOptune™ is a wearable and portable, FDA-approved device that has been shown in clinical trials to safely deliver continuous therapy to the area of your brain where your GBM tumor is located.

You may be worried about what kind of effects Optune can have on other parts of your body. That’s what makes Optune different. Optune does not enter your bloodstream and has not been shown to affect cells in other parts of your body.

Optune delivers therapy through 4 adhesive patches, called transducer arrays. These transducer arrays are applied to your scalp and are connected to the device and battery. It is recommended that you use Optune for at least 18 hours a day.

Depending on where you are in your diagnosis and treatment plan, you may need to use Optune along with another therapy or alone:

  • For people with newly diagnosed GBM, Optune is used together with the chemotherapy temozolomide (TMZ)
  • For people with recurrent GBM, Optune is used alone